Lo Loestrin Fe is a combined oral contraceptive that contains two different hormones (an estrogen and a progestin). This prescription birth control pill contains a low dose of hormones and works to prevent pregnancy by stopping ovulation, changing the cervical mucus, and altering the lining of the uterus. Common side effects include nausea, vomiting, and headaches.
What Is Lo Loestrin Fe?
Lo Loestrin™ Fe (norethindrone/ethinyl estradiol) is an oral contraceptive (birth control pill) approved for preventing pregnancy. This particular birth control pill offers women a very low dose of hormones while still providing excellent protection from pregnancy.
Lo Loestrin Fe is made by Warner Chilcott Company, LLC.
How Does Lo Loestrin Fe Work?
Lo Loestrin Fe is a combination oral contraceptive that contains an estrogen and a progestin. The drug primarily prevents pregnancy by stopping ovulation (the maturation and release of eggs from the ovaries).
However, it also prevents pregnancy in two other, minor ways. Lo Loestrin Fe alters the cervical mucus (the fluid of the cervix, which is the lower, narrow part of the uterus that is connected to the vagina), making it more difficult for sperm to enter the uterus. The drug also alters the lining of the uterus (the endometrium), making it less receptive to an embryo.
The first 24 tablets in each pack of Lo Loestrin Fe contain both of the active hormones. The next two tablets contain only the ethinyl estradiol (estrogen) hormone. The last two tablets do not contain any active hormones, but they do contain iron. The iron might possibly help prevent anemia that could occur due to blood loss during a woman's period, although it is questionable if taking iron two days a month really makes any difference.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Lo Loestrin Fe [package insert]. Rockaway, NJ: Warner Chilcott Company, LLC.;2010 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed November 16, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click